COCRYSTAL PHARMA, INC. Operating Lease, Expense
COCRYSTAL PHARMA, INC. (COCP) reported Operating Lease, Expense of $204.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-08-13
- COCRYSTAL PHARMA, INC. operating lease, expense for the quarter ending 2026-06-30 was $102.00K, a 0.00% change year-over-year.
- COCRYSTAL PHARMA, INC. operating lease, expense for the quarter ending 2026-03-31 was $102.00K, a 0.97% decline year-over-year.
- COCRYSTAL PHARMA, INC. operating lease, expense for the quarter ending 2025-12-31 was $270.00K, a 2.53% decline year-over-year.
- COCRYSTAL PHARMA, INC. operating lease, expense for the quarter ending 2025-09-30 was $103.00K, a 0.98% increase year-over-year.
- COCRYSTAL PHARMA, INC. operating lease, expense for fiscal 2025 was $578.00K, a 1.76% increase from fiscal 2024.
- COCRYSTAL PHARMA, INC. operating lease, expense for fiscal 2024 was $568.00K, a 143.78% increase from fiscal 2023.
- COCRYSTAL PHARMA, INC. operating lease, expense for fiscal 2023 was $233.00K, a 14.78% increase from fiscal 2022.
- COCRYSTAL PHARMA, INC. operating lease, expense for fiscal 2022 was $203.00K, a 5.73% increase from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 6 month as first filed | Operating Lease, Expense 9 month | Operating Lease, Expense 9 month as first filed | Operating Lease, Expense 12 month | Operating Lease, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $102.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $204.00K 10-Q · filed 2026-08-13 | $474.00K derived: sum of 3 quarters · filed 2026-08-13 | $577.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | $102.00K 10-Q · filed 2026-05-15 | $372.00K derived: sum of 2 quarters · filed 2026-05-15 | $475.00K derived: sum of 3 quarters · filed 2026-05-15 | $577.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | $270.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $373.00K derived: sum of 2 quarters · filed 2026-03-31 | $475.00K derived: sum of 3 quarters · filed 2026-08-13 | $578.00K 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $103.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $205.00K derived: sum of 2 quarters · filed 2026-08-13 | $308.00K 10-Q · filed 2025-11-14 | $585.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $102.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $205.00K 10-Q · filed 2026-08-13 | $482.00K derived: sum of 3 quarters · filed 2026-08-13 | $584.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | $103.00K 10-Q · filed 2026-05-15 | $380.00K derived: sum of 2 quarters · filed 2026-05-15 | $482.00K derived: sum of 3 quarters · filed 2026-05-15 | $584.00K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | $277.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $379.00K derived: sum of 2 quarters · filed 2026-03-31 | $481.00K derived: sum of 3 quarters · filed 2026-03-31 | $568.00K 10-K · filed 2026-03-31 | $393.00K 10-K · filed 2025-03-31 | ||
| 2024-09-30 | $102.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $204.00K derived: sum of 2 quarters · filed 2025-11-14 | $291.00K 10-Q · filed 2025-11-14 | $349.00K derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | $102.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $189.00K 10-Q · filed 2025-08-14 | $247.00K derived: sum of 3 quarters · filed 2025-08-14 | $306.00K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $87.00K 10-Q · filed 2025-05-15 | $145.00K derived: sum of 2 quarters · filed 2025-05-15 | $204.00K derived: sum of 3 quarters · filed 2025-05-15 | $262.00K derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $117.00K derived: sum of 2 quarters · filed 2025-03-31 | $175.00K derived: sum of 3 quarters · filed 2025-03-31 | $233.00K 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $117.00K derived: sum of 2 quarters · filed 2024-11-13 | $175.00K 10-Q · filed 2024-11-13 | $203.00K derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | $58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $116.00K 10-Q · filed 2024-08-14 | $144.00K derived: sum of 3 quarters · filed 2024-08-14 | $203.00K derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | $58.00K 10-Q · filed 2024-05-13 | $86.00K derived: sum of 2 quarters · filed 2024-05-13 | $145.00K derived: sum of 3 quarters · filed 2024-05-13 | $203.00K derived: sum of 4 quarters · filed 2024-05-13 | |||
| 2022-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $87.00K derived: sum of 2 quarters · filed 2023-11-13 | $145.00K derived: sum of 3 quarters · filed 2023-11-13 | $203.00K 10-K · filed 2023-03-29 | |||
| 2022-09-30 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $117.00K derived: sum of 2 quarters · filed 2023-11-13 | $175.00K 10-Q · filed 2023-11-13 | $195.00K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $116.00K 10-Q · filed 2023-08-14 | $136.00K derived: sum of 3 quarters · filed 2023-08-14 | $194.00K derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $58.00K 10-Q · filed 2023-05-15 | $78.00K derived: sum of 2 quarters · filed 2023-05-15 | $136.00K derived: sum of 3 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $78.00K derived: sum of 2 quarters · filed 2023-03-29 | $192.00K 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $172.00K 10-Q · filed 2022-11-14 | $143.00K 10-Q · filed 2021-11-15 | ||||
| 2021-06-30 | $114.00K 10-Q · filed 2022-08-15 | $95.00K 10-Q · filed 2021-08-16 | |||||
| 2020-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $91.00K derived: sum of 2 quarters · filed 2022-03-23 | $179.00K 10-K · filed 2022-03-23 | ||||
| 2020-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $133.00K 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | $88.00K 10-Q · filed 2021-08-16 | ||||||
| 2019-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $72.00K 10-Q · filed 2020-08-06 | |||||
| 2019-03-31 | $43.00K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |